Newsletter | January 14, 2025

01.14.25 -- Seeing Firsthand The Transformative Impact Of AI On Pharmacovigilance And Clinical Research

SPONSOR

2025 BioPlan's 22nd Annual Survey--Biopharmaceutical Manufacturing

For over 20 years, we continue to be the leader in providing the biopharma industry's most comprehensive benchmarking analysis. We invite you to participate in our 22nd Annual Survey in Biopharmaceutical Manufacturing! For all completed, qualified responses, we'll send an Amazon egift card, a copy of the summary results (mid-2025), and our 2025 Top Trends in Biomanufacturing White Paper.

FEATURED EDITORIAL

The Impact Of AI On Pharmacovigilance And Clinical Research

Consultants Aashna Goyal and Guriqbal Singh share first-persona accounts of how AI is transforming pharmacovigilance and clinical research by improving data processing, enhancing decision-making, and accelerating drug development.

INDUSTRY INSIGHTS

Trends And Challenges In The Pharmaceutical Industry

Explore the latest trends and strategic collaborations driving groundbreaking pharmaceutical advancements and their profound impact on the future of medicine and patient care.

Efficient Development Of Drug Products: Selecting A Dissolution Media

With so many different media available that vary widely in properties and composition, it is important to know how to select a dissolution media that can effectively test formulation robustness.

Increasing Bioavailability With Amorphous Solid Dosage Formulations

Discover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.

Strategic Space Management

A pharmaceutical company facing storage space issues decided to outsource its reference samples to Q1 Scientific, a stability storage service provider, resulting in cost savings.

Organ-Chips For Drug Development

Delve into how Organ-on-Chip technology significantly enhances drug development processes and improves the accuracy of clinical translation, leading to more effective and reliable therapeutic outcomes.

MOST POPULAR NEWS

PostEra Announces Expansion To $610M In Their AI Drug Discovery Collaboration With Pfizer

Variant Bio Announces Multi-Year Research Partnership With Novo Nordisk

QUANTRO Therapeutics Achieves Breakthrough In Transcriptomic Drug Discovery

How A Single Nitrogen Atom Could Transform The Future Of Drug Discovery

A New Computational Model Can Predict Antibody Structures More Accurately

Biocytogen & Acepodia To Advance Bispecific Antibody & Dual-Payload ADCs

PhenoVista Biosciences & NETRI To Expand Organ-On-Chip Service Offerings

AliveGen Receives FDA ODD For ALG-801 For Pulmonary Arterial Hypertension

Star Therapeutics Receives FDA Fast Track Designation For VGA039 In VWD

Acellera Therapeutics Unveils AceForce 1.0

Vividion Therapeutics Acquires Tavros Therapeutics

SOLUTIONS

Frequently Asked Questions About Stability Profiling Experiments

Your Molecule. Our Mission.

Solid Form Services